Hedgehog pathway activation parallels histologic severity of injury and fibrosis in human nonalcoholic fatty liver disease

Cynthia D Guy, Ayako Suzuki, Marzena Zdanowicz, Manal F Abdelmalek, James Burchette, Aynur Unalp, Anna Mae Diehl, Bradley Aouizerat, NASH CRN

Research output: Contribution to journalArticle

Abstract

UNLABELLED: The Hedgehog (HH)-signaling pathway mediates several processes that are deregulated in patients with metabolic syndrome (e.g., fat mass regulation, vascular/endothelial remodeling, liver injury and repair, and carcinogenesis). The severity of nonalcoholic fatty liver disease (NAFLD) and metabolic syndrome generally correlate. Therefore, we hypothesized that the level of HH-pathway activation would increase in parallel with the severity of liver damage in NAFLD. To assess potential correlations between known histologic and clinical predictors of advanced liver disease and HH-pathway activation, immunohistochemistry was performed on liver biopsies from a large, well-characterized cohort of NAFLD patients (n = 90) enrolled in the Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN) Database 1 study. Increased HH activity (evidenced by accumulation of HH-ligand-producing cells and HH-responsive target cells) strongly correlated with portal inflammation, ballooning, and fibrosis stage (each P < 0.0001), supporting a relationship between HH-pathway activation and liver damage. Pathway activity also correlated significantly with markers of liver repair, including numbers of hepatic progenitors and myofibroblastic cells (both P < 0.03). In addition, various clinical parameters that have been linked to histologically advanced NAFLD, including increased patient age (P < 0.005), body mass index (P < 0.002), waist circumference (P < 0.0007), homeostatic model assessment of insulin resistance (P < 0.0001), and hypertension (P < 0.02), correlated with hepatic HH activity.

CONCLUSION: In NAFLD patients, the level of hepatic HH-pathway activity is highly correlated with the severity of liver damage and with metabolic syndrome parameters that are known to be predictive of advanced liver disease. Hence, deregulation of the HH-signaling network may contribute to the pathogenesis and sequelae of liver damage that develops with metabolic syndrome.

Original languageEnglish (US)
Pages (from-to)1711-21
Number of pages11
JournalHepatology
Volume55
Issue number6
DOIs
StatePublished - Jun 2012

Fingerprint

Fibrosis
Liver
Wounds and Injuries
Liver Diseases
Non-alcoholic Fatty Liver Disease
Waist Circumference
Insulin Resistance
Hepatocytes
Carcinogenesis
Body Mass Index
Stem Cells
Immunohistochemistry
Fats
Databases
Ligands
Hypertension
Inflammation
Biopsy
Research

Keywords

  • Adult
  • Aged
  • Cross-Sectional Studies
  • Fatty Liver
  • Female
  • Hedgehog Proteins
  • Humans
  • Kruppel-Like Transcription Factors
  • Liver
  • Liver Cirrhosis
  • Male
  • Middle Aged
  • Myofibroblasts
  • Non-alcoholic Fatty Liver Disease
  • Nuclear Proteins
  • Severity of Illness Index
  • Signal Transduction
  • Stem Cells

Cite this

Guy, C. D., Suzuki, A., Zdanowicz, M., Abdelmalek, M. F., Burchette, J., Unalp, A., ... NASH CRN (2012). Hedgehog pathway activation parallels histologic severity of injury and fibrosis in human nonalcoholic fatty liver disease. Hepatology, 55(6), 1711-21. https://doi.org/10.1002/hep.25559

Hedgehog pathway activation parallels histologic severity of injury and fibrosis in human nonalcoholic fatty liver disease. / Guy, Cynthia D; Suzuki, Ayako; Zdanowicz, Marzena; Abdelmalek, Manal F; Burchette, James; Unalp, Aynur; Diehl, Anna Mae; Aouizerat, Bradley; NASH CRN.

In: Hepatology, Vol. 55, No. 6, 06.2012, p. 1711-21.

Research output: Contribution to journalArticle

Guy, CD, Suzuki, A, Zdanowicz, M, Abdelmalek, MF, Burchette, J, Unalp, A, Diehl, AM, Aouizerat, B & NASH CRN 2012, 'Hedgehog pathway activation parallels histologic severity of injury and fibrosis in human nonalcoholic fatty liver disease', Hepatology, vol. 55, no. 6, pp. 1711-21. https://doi.org/10.1002/hep.25559
Guy, Cynthia D ; Suzuki, Ayako ; Zdanowicz, Marzena ; Abdelmalek, Manal F ; Burchette, James ; Unalp, Aynur ; Diehl, Anna Mae ; Aouizerat, Bradley ; NASH CRN. / Hedgehog pathway activation parallels histologic severity of injury and fibrosis in human nonalcoholic fatty liver disease. In: Hepatology. 2012 ; Vol. 55, No. 6. pp. 1711-21.
@article{1cd584ac788148c394752db555159382,
title = "Hedgehog pathway activation parallels histologic severity of injury and fibrosis in human nonalcoholic fatty liver disease",
abstract = "UNLABELLED: The Hedgehog (HH)-signaling pathway mediates several processes that are deregulated in patients with metabolic syndrome (e.g., fat mass regulation, vascular/endothelial remodeling, liver injury and repair, and carcinogenesis). The severity of nonalcoholic fatty liver disease (NAFLD) and metabolic syndrome generally correlate. Therefore, we hypothesized that the level of HH-pathway activation would increase in parallel with the severity of liver damage in NAFLD. To assess potential correlations between known histologic and clinical predictors of advanced liver disease and HH-pathway activation, immunohistochemistry was performed on liver biopsies from a large, well-characterized cohort of NAFLD patients (n = 90) enrolled in the Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN) Database 1 study. Increased HH activity (evidenced by accumulation of HH-ligand-producing cells and HH-responsive target cells) strongly correlated with portal inflammation, ballooning, and fibrosis stage (each P < 0.0001), supporting a relationship between HH-pathway activation and liver damage. Pathway activity also correlated significantly with markers of liver repair, including numbers of hepatic progenitors and myofibroblastic cells (both P < 0.03). In addition, various clinical parameters that have been linked to histologically advanced NAFLD, including increased patient age (P < 0.005), body mass index (P < 0.002), waist circumference (P < 0.0007), homeostatic model assessment of insulin resistance (P < 0.0001), and hypertension (P < 0.02), correlated with hepatic HH activity.CONCLUSION: In NAFLD patients, the level of hepatic HH-pathway activity is highly correlated with the severity of liver damage and with metabolic syndrome parameters that are known to be predictive of advanced liver disease. Hence, deregulation of the HH-signaling network may contribute to the pathogenesis and sequelae of liver damage that develops with metabolic syndrome.",
keywords = "Adult, Aged, Cross-Sectional Studies, Fatty Liver, Female, Hedgehog Proteins, Humans, Kruppel-Like Transcription Factors, Liver, Liver Cirrhosis, Male, Middle Aged, Myofibroblasts, Non-alcoholic Fatty Liver Disease, Nuclear Proteins, Severity of Illness Index, Signal Transduction, Stem Cells",
author = "Guy, {Cynthia D} and Ayako Suzuki and Marzena Zdanowicz and Abdelmalek, {Manal F} and James Burchette and Aynur Unalp and Diehl, {Anna Mae} and Bradley Aouizerat and {NASH CRN}",
note = "Copyright {\circledC} 2012 American Association for the Study of Liver Diseases.",
year = "2012",
month = "6",
doi = "10.1002/hep.25559",
language = "English (US)",
volume = "55",
pages = "1711--21",
journal = "Hepatology",
issn = "0270-9139",
publisher = "John Wiley and Sons Ltd",
number = "6",

}

TY - JOUR

T1 - Hedgehog pathway activation parallels histologic severity of injury and fibrosis in human nonalcoholic fatty liver disease

AU - Guy, Cynthia D

AU - Suzuki, Ayako

AU - Zdanowicz, Marzena

AU - Abdelmalek, Manal F

AU - Burchette, James

AU - Unalp, Aynur

AU - Diehl, Anna Mae

AU - Aouizerat, Bradley

AU - NASH CRN

N1 - Copyright © 2012 American Association for the Study of Liver Diseases.

PY - 2012/6

Y1 - 2012/6

N2 - UNLABELLED: The Hedgehog (HH)-signaling pathway mediates several processes that are deregulated in patients with metabolic syndrome (e.g., fat mass regulation, vascular/endothelial remodeling, liver injury and repair, and carcinogenesis). The severity of nonalcoholic fatty liver disease (NAFLD) and metabolic syndrome generally correlate. Therefore, we hypothesized that the level of HH-pathway activation would increase in parallel with the severity of liver damage in NAFLD. To assess potential correlations between known histologic and clinical predictors of advanced liver disease and HH-pathway activation, immunohistochemistry was performed on liver biopsies from a large, well-characterized cohort of NAFLD patients (n = 90) enrolled in the Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN) Database 1 study. Increased HH activity (evidenced by accumulation of HH-ligand-producing cells and HH-responsive target cells) strongly correlated with portal inflammation, ballooning, and fibrosis stage (each P < 0.0001), supporting a relationship between HH-pathway activation and liver damage. Pathway activity also correlated significantly with markers of liver repair, including numbers of hepatic progenitors and myofibroblastic cells (both P < 0.03). In addition, various clinical parameters that have been linked to histologically advanced NAFLD, including increased patient age (P < 0.005), body mass index (P < 0.002), waist circumference (P < 0.0007), homeostatic model assessment of insulin resistance (P < 0.0001), and hypertension (P < 0.02), correlated with hepatic HH activity.CONCLUSION: In NAFLD patients, the level of hepatic HH-pathway activity is highly correlated with the severity of liver damage and with metabolic syndrome parameters that are known to be predictive of advanced liver disease. Hence, deregulation of the HH-signaling network may contribute to the pathogenesis and sequelae of liver damage that develops with metabolic syndrome.

AB - UNLABELLED: The Hedgehog (HH)-signaling pathway mediates several processes that are deregulated in patients with metabolic syndrome (e.g., fat mass regulation, vascular/endothelial remodeling, liver injury and repair, and carcinogenesis). The severity of nonalcoholic fatty liver disease (NAFLD) and metabolic syndrome generally correlate. Therefore, we hypothesized that the level of HH-pathway activation would increase in parallel with the severity of liver damage in NAFLD. To assess potential correlations between known histologic and clinical predictors of advanced liver disease and HH-pathway activation, immunohistochemistry was performed on liver biopsies from a large, well-characterized cohort of NAFLD patients (n = 90) enrolled in the Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN) Database 1 study. Increased HH activity (evidenced by accumulation of HH-ligand-producing cells and HH-responsive target cells) strongly correlated with portal inflammation, ballooning, and fibrosis stage (each P < 0.0001), supporting a relationship between HH-pathway activation and liver damage. Pathway activity also correlated significantly with markers of liver repair, including numbers of hepatic progenitors and myofibroblastic cells (both P < 0.03). In addition, various clinical parameters that have been linked to histologically advanced NAFLD, including increased patient age (P < 0.005), body mass index (P < 0.002), waist circumference (P < 0.0007), homeostatic model assessment of insulin resistance (P < 0.0001), and hypertension (P < 0.02), correlated with hepatic HH activity.CONCLUSION: In NAFLD patients, the level of hepatic HH-pathway activity is highly correlated with the severity of liver damage and with metabolic syndrome parameters that are known to be predictive of advanced liver disease. Hence, deregulation of the HH-signaling network may contribute to the pathogenesis and sequelae of liver damage that develops with metabolic syndrome.

KW - Adult

KW - Aged

KW - Cross-Sectional Studies

KW - Fatty Liver

KW - Female

KW - Hedgehog Proteins

KW - Humans

KW - Kruppel-Like Transcription Factors

KW - Liver

KW - Liver Cirrhosis

KW - Male

KW - Middle Aged

KW - Myofibroblasts

KW - Non-alcoholic Fatty Liver Disease

KW - Nuclear Proteins

KW - Severity of Illness Index

KW - Signal Transduction

KW - Stem Cells

U2 - 10.1002/hep.25559

DO - 10.1002/hep.25559

M3 - Article

VL - 55

SP - 1711

EP - 1721

JO - Hepatology

JF - Hepatology

SN - 0270-9139

IS - 6

ER -